SBIR Phase II New Risk Assessment/Intervention For Pregnant Woman

SBIR 第二阶段针对孕妇的新风险评估/干预

基本信息

批准号：
7188039
负责人：
Robin Inlander
金额：
$ 30.36万
依托单位：
BEHAVIORAL RESEARCH, INC.
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
起止时间：
2003-06-01 至 2009-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7188039
关键词：
Accountability Alcohol Nutrition Alcohol consumption Area Arts Back Behavior Birth Clinic Clinical Communities Computer software Computers Contracts Data Diagnostic Discipline of obstetrics Documentation Drug usage Elements Feedback Feeling Fetus First Pregnancy Trimester Funding HIV Health Maintenance Organizations Health Personnel Hispanic Americans Hour Image Individual Intention Intervention Interview Learning Length Low income Maintenance Marketing Modeling Motivation Movement Not Hispanic or Latino Numbers Online Systems Operative Surgical Procedures Outcome Paper Parents Partner Abuse Patient Self-Report Patient currently pregnant Patients Personal Satisfaction Pharmaceutical Preparations Phase Population Pregnancy Pregnant Women Prenatal care Prevention Printing Provider Psychologist Questionnaires Race Randomized Randomized Controlled Clinical Trials Randomized Controlled Trials Rate Reaction Readiness Reporting Research Research Personnel Resources Risk Risk Assessment Risk Behaviors Small Business Funding Mechanisms Small Business Innovation Research Grant Smoking Staging Standards of Weights and Measures Stress Structure Substance abuse problem Surveys System Testing Text Third Pregnancy Trimester Time Translating Translations Update Validation Visit Vocabulary Woman base behavior change cigarette smoking computerized cost design follow-up improved instrument maternal drug use motivational intervention nutrition prenatal prevent programs prototype quality assurance racial and ethnic response self reported behavior usability user-friendly

项目摘要

DESCRIPTION (provided by applicant): Drug use is common among pregnant women, yet only an estimated 32 percent to 42 percent of prenatal care providers routinely ask patients about their use of drugs. Prenatal visits afford a unique opportunity for providers to educate women about prevention, and to detect drug use during pregnancy. To facilitate efficient use of provider resources, we developed a computerized interactive survey interview, the Pregnancy Information Program (PIP) that has been extensively tested in non-Hispanic white, Hispanic, and American Indian populations. Earlier studies demonstrated that the PIP was well received in multiple ethnic/racial pregnant populations. More importantly, the PIP evoked more honest responses regarding drug use and other socially stigmatized behaviors than paper-and-pencil questionnaires. In Phase I we updated the program, integrated current diagnostic standards, added a tailored motivational intervention, and incorporated audio and video elements to the program. For this Phase II project, we propose to further enhance the software capabilities, expand the domains of use to clinicians, and develop a commercial quality CD ROM prototype of the entire instrument. We will beta test the completed instrument in 6 community women's clinics, to determine its acceptability and ease of use, through anonymous clinician surveys and rates of completion. We will also conduct a randomized, controlled clinical trial of 346 pregnant women to determine PIP's ability to promote behavior change from the initial to the third trimesters of pregnancy. Primary outcomes evaluated in this trial include self-reported changes in nutrition, drug use, alcohol use, cigarette smoking, HIV risk behavior, and partner abuse avoidance. We will also assess stages of readiness to change, where change is not yet manifest. Subjects in their first trimester will be randomized to complete the PIP or a computer questionnaire minus the educational and customized motivational feedback. Both groups also will receive printed educational information. In their third trimesters, subjects will complete a second computer-based questionnaire to determine current behaviors, and will participate in a personal interview regarding their reaction to PIP. Paired data will be analyzed using generalized linear mixed models to estimate differences between and within groups over time. This study will reveal the potential of the PIP to enhance prenatal healthy behaviors, and improve birth outcomes, while saving providers time.

描述（由申请人提供）：吸毒在孕妇中很常见，但据估计，只有 32% 至 42% 的产前护理人员会定期询问患者吸毒情况。产前检查为提供者提供了一个独特的机会，对妇女进行预防教育并发现怀孕期间的药物使用情况。为了促进有效利用提供者资源，我们开发了一种计算机化交互式调查访谈，即怀孕信息计划 (PIP)，该计划已在非西班牙裔白人、西班牙裔和美洲印第安人群体中进行了广泛测试。早期研究表明，PIP 受到多个民族/种族怀孕人群的欢迎。更重要的是，与纸笔问卷调查相比，PIP 引发了有关吸毒和其他社会耻辱行为的更诚实的反应。在第一阶段，我们更新了程序，整合了当前的诊断标准，添加了量身定制的激励干预，并将音频和视频元素融入到程序中。对于这个二期项目，我们建议进一步增强软件功能，扩大临床医生的使用范围，并开发整个仪器的商业质量CD ROM原型。我们将在 6 个社区妇女诊所对已完成的仪器进行 Beta 测试，通过匿名临床医生调查和完成率来确定其可接受性和易用性。我们还将对 346 名孕妇进行一项随机对照临床试验，以确定 PIP 促进妊娠初期至妊娠晚期行为改变的能力。该试验评估的主要结果包括自我报告的营养、药物使用、饮酒、吸烟、艾滋病毒危险行为和避免伴侣虐待方面的变化。我们还将评估变革的准备阶段，其中变革尚未显现。妊娠早期的受试者将被随机分配完成 PIP 或计算机问卷，减去教育和定制的动机反馈。两个小组还将收到印刷版的教育信息。在妊娠晚期，受试者将完成第二份基于计算机的调查问卷，以确定当前的行为，并将参加有关他们对 PIP 反应的个人访谈。将使用广义线性混合模型对配对数据进行分析，以估计组间和组内随时间的差异。这项研究将揭示 PIP 在增强产前健康行为、改善出生结果、同时节省提供者时间方面的潜力。